InvestorsHub Logo
icon url

arbytrader

07/29/17 4:41 PM

#8934 RE: DayDreeming #8927

the question to the board is...do you trust Michael Redman enough to use those shares wisely? I certainly do and for the fact that Oncolix shareholders approved of such a notion indicates total trust in the CEO....will they issue new shares in the near future?..probably not...but would they issue more shares down the road to sustain operations? it's a possibility and in fact such a thing could benefit us in the long run. here is a list of companies that partnered with GHS like Oncolix with their current outstanding shares and PPS...all listed on the NASDAQ. now imagine where you will see Oncolix.

Amgen
735,399,000 O/S
$174.54/share

Astrazeneca
412,122,000 O/S
$30.27/share

Novartis
329,287,000 O/S
$84.75/share